Cargando…

Publisher Correction: Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors

Detalles Bibliográficos
Autores principales:	Lai, Edward Chia‑Cheng, Liang, Hsun‑Yin, Huang, Ya‑Chun, Huang, Wei‑I., Chao, Pi‑Hui, Chen, Wen‑Wen, Weng, Meng‑Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Publisher Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511037/ https://www.ncbi.nlm.nih.gov/pubmed/34642380 http://dx.doi.org/10.1038/s41598-021-99382-x

Ejemplares similares

Association between 9-month isoniazid prophylaxis of latent tuberculosis and severe hepatitis in patients treated with TNF inhibitors
por: Lai, Edward Chia-Cheng, et al.
Publicado: (2021)

Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
por: Lai, Wendy A., et al.
Publicado: (2022)

Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
por: McClintock, Adelaide H., et al.
Publicado: (2017)

Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area
por: Moon, Hyung Hwan, et al.
Publicado: (2017)

A Case of Acute Liver Failure in a Patient on Isoniazid Prophylaxis for Latent Tuberculosis
por: Philipose, Jobin, et al.
Publicado: (2022)

Cost effectiveness of three months of rifapentine and isoniazid for latent tuberculosis in Syrian refugees
por: Ilaiwy, Ghassan, et al.
Publicado: (2021)

3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review
por: Assefa, Yibeltal, et al.
Publicado: (2018)

Association of Drug Metabolic Enzyme Genetic Polymorphisms and Adverse Drug Reactions in Patients Receiving Rifapentine and Isoniazid Therapy for Latent Tuberculosis
por: Yu, Ya-Yen, et al.
Publicado: (2019)

Publisher Correction: Latent class analysis-derived classification improves the cancer-specific death stratification of molecular subtyping in colorectal cancer
por: Zhou, Wen, et al.
Publicado: (2023)

Publisher Correction: Extension and update of multiscale monthly household carbon footprint in Japan from 2011 to 2022
por: Huang, Liqiao, et al.
Publicado: (2023)

Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure
por: Lu, Lenette L., et al.
Publicado: (2019)

Publisher Correction: Five-month-old infants detect affiliation in colaughter
por: Vouloumanos, Athena, et al.
Publicado: (2019)

Effect of isoniazid on antigen-specific interferon-γ secretion in latent tuberculosis
por: Torres, Martha, et al.
Publicado: (2015)

1694 Risk factors and outcomes of isoniazid hepatotoxicity in children with latent tuberculosis
por: Devrim, Ilker, et al.
Publicado: (2014)

Publisher Correction: Long-range spatio-temporal correlations in multimode fibers for pulse delivery
por: Xiong, Wen, et al.
Publicado: (2020)

Publisher Correction: New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis
por: Wang, Hung-Wei, et al.
Publicado: (2018)

Adherence to nine-month isoniazid for latent tuberculosis infection in healthcare workers: a prospective study in a tertiary hospital
por: Chung, Sung Jun, et al.
Publicado: (2020)

Seizures in an Immunocompetent Adult From Treatment of Latent Tuberculosis Infection: Is Isoniazid to Blame?
por: Navalkele, Bhagyashri, et al.
Publicado: (2020)

Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis
por: Oscanoa, Teodoro J., et al.
Publicado: (2023)

Completion Rate and Side-Effect Profile of Three-Month Isoniazid and Rifapentine Treatment for Latent Tuberculosis Infection in an Urban County Jail
por: Juarez-Reyes, Maria, et al.
Publicado: (2016)

Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study
por: Lam, Chee Kin, et al.
Publicado: (2018)

Publisher Correction: Structural basis for mismatch surveillance by CRISPR–Cas9
por: Bravo, Jack P. K., et al.
Publicado: (2022)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Short‐course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide
por: Liou, Bo‐Huang, et al.
Publicado: (2021)

Publisher Correction: Bicontinuous oxide heteroepitaxy with enhanced photoconductivity
por: Shao, Pao-Wen, et al.
Publicado: (2023)

Publisher Correction: M. tuberculosis infection and antigen specific cytokine response in healthcare workers frequently exposed to tuberculosis
por: Essone, Paulin N., et al.
Publicado: (2019)

Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2018)

Publisher Correction: R-loop formation and conformational activation mechanisms of Cas9
por: Pacesa, Martin, et al.
Publicado: (2023)

Publisher Correction To: Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework
por: Kadiamada-Ibarra, Hemant, et al.
Publicado: (2022)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Publisher Correction: HIF-1 stabilization in T cells hampers the control of Mycobacterium tuberculosis infection
por: Liu, Ruining, et al.
Publicado: (2022)

Publisher Correction: Bifurcation analysis of a tuberculosis progression model for drug target identification
por: Flores-Garza, Eliezer, et al.
Publicado: (2023)

Publisher Correction: FGF signalling controls the specification of hair placode-derived SOX9 positive progenitors to Merkel cells
por: Nguyen, Minh Binh, et al.
Publicado: (2018)

Publisher Correction to: delivery systems of CRISPR/Cas9-based cancer gene therapy
por: Biagioni, Alessio, et al.
Publicado: (2019)

Publisher Correction: Delay in primordial germ cell migration in adamts9 knockout zebrafish
por: Carver, Jonathan J., et al.
Publicado: (2021)

Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors
por: Kalbasi, Anusha, et al.
Publicado: (2022)

Publisher Correction: Self-assembly growth of electrolytic silver dendrites
por: Tsai, Wen‑Chieh, et al.
Publicado: (2022)

Does an Isoniazid Prophylaxis Register Improve Tuberculosis Contact Management in South African Children?
por: van Soelen, Nelda, et al.
Publicado: (2013)

Tuberculosis and isoniazid prophylaxis among adult HIV positive patients on ART in Northwest Ethiopia
por: Geremew, Demeke, et al.
Publicado: (2022)

Publisher Correction: Genomic analysis of the emergence of drug-resistant strains of Mycobacterium tuberculosis in the Middle East
por: Alyamani, Essam J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lrktbkibk1ebhq6m8u7b1lk0md